ResMed, Inc. (RMD)
239.72
+2.84
(+1.20%)
USD |
NYSE |
Nov 20, 10:46
ResMed Cash from Operations (Quarterly) : 422.42M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 422.42M |
| June 30, 2026 | 454.63M |
| March 31, 2026 | 554.13M |
| December 31, 2025 | 339.74M |
| September 30, 2025 | 457.32M |
| June 30, 2025 | 538.77M |
| March 31, 2025 | 578.66M |
| December 31, 2024 | 308.62M |
| September 30, 2024 | 325.54M |
| June 30, 2024 | 440.11M |
| March 31, 2024 | 402.03M |
| December 31, 2023 | 272.83M |
| September 30, 2023 | 286.28M |
| June 30, 2023 | 237.44M |
| March 31, 2023 | 282.56M |
| December 31, 2022 | 128.64M |
| September 30, 2022 | 44.66M |
| June 30, 2022 | 79.49M |
| March 31, 2022 | 117.44M |
| December 31, 2021 | 219.88M |
| September 30, 2021 | -65.66M |
| June 30, 2021 | 226.52M |
| March 31, 2021 | 196.28M |
| December 31, 2020 | 169.92M |
| September 30, 2020 | 144.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 330.26M |
| March 31, 2020 | 239.70M |
| December 31, 2019 | 69.93M |
| September 30, 2019 | 162.36M |
| June 30, 2019 | 141.82M |
| March 31, 2019 | 139.65M |
| December 31, 2018 | 129.47M |
| September 30, 2018 | 48.12M |
| June 30, 2018 | 129.42M |
| March 31, 2018 | 149.08M |
| December 31, 2017 | 132.55M |
| September 30, 2017 | 93.98M |
| June 30, 2017 | 140.31M |
| March 31, 2017 | 67.60M |
| December 31, 2016 | 119.90M |
| September 30, 2016 | 86.24M |
| June 30, 2016 | 142.96M |
| March 31, 2016 | 124.75M |
| December 31, 2015 | 158.15M |
| September 30, 2015 | 122.07M |
| June 30, 2015 | 99.70M |
| March 31, 2015 | 90.94M |
| December 31, 2014 | 106.00M |
| September 30, 2014 | 86.54M |
| June 30, 2014 | 115.58M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Accuray, Inc. | -4.657M |
| Orthofix Medical, Inc. | 0.498M |
| Rockwell Medical, Inc. | -1.526M |
| Microbot Medical, Inc. | -5.407M |
| Stereotaxis, Inc. | -4.177M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 392.06M |
| Cash from Financing (Quarterly) | -1.278B |
| Free Cash Flow | 1.588B |
| Free Cash Flow Per Share (Quarterly) | 2.589 |
| Free Cash Flow to Equity (Quarterly) | 586.59M |
| Free Cash Flow to Firm (Quarterly) | 385.06M |
| Free Cash Flow Yield | 4.71% |